Cardiol Therapeutics (CRDL) Earnings Date & Reports

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CRDL is expected to report earnings to rise 40.11% to -5 cents per share on November 12

Cardiol Therapeutics CRDL Stock Earnings Reports

Q3'26

Est.

$-0.05

Q2'26

Beat

by $0.03

Q1'26

Est.

$-0.07

Q4'25

Beat

by $0.03

Q3'25

Missed

by $0.01

The last earnings report on August 13 showed earnings per share of -3 cents, beating the estimate of -6 cents. With 627.33K shares outstanding, the current market capitalization sits at 208.71M.

View a ticker or compare two or three

CRDL

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for CRDL